In the present study, we examined the association between preoperative serum levels of lipocalin-2 and MMP-9 and disease-free survival (DFS) and determined the potential of both proteins as noninvasive biomarkers in predicting the recurrence of breast cancer. The gene discussed is MMP9; the disease is breast cancer.